CRIS
Price
$1.59
Change
+$0.09 (+6.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
14.96M
REVB
Price
$2.83
Change
-$0.03 (-1.05%)
Updated
Apr 24, 01:45 PM (EDT)
Capitalization
2.58M
Ad is loading...

CRIS vs REVB

Header iconCRIS vs REVB Comparison
Open Charts CRIS vs REVBBanner chart's image
Curis
Price$1.59
Change+$0.09 (+6.00%)
Volume$1.13K
Capitalization14.96M
Revelation Biosciences
Price$2.83
Change-$0.03 (-1.05%)
Volume$160
Capitalization2.58M
CRIS vs REVB Comparison Chart
Loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRIS vs. REVB commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Buy and REVB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CRIS: $1.50 vs. REVB: $2.86)
Brand notoriety: CRIS and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 269% vs. REVB: 88%
Market capitalization -- CRIS: $14.96M vs. REVB: $2.58M
CRIS [@Biotechnology] is valued at $14.96M. REVB’s [@Biotechnology] market capitalization is $2.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileREVB’s FA Score has 2 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • REVB’s FA Score: 2 green, 3 red.
According to our system of comparison, REVB is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 4 TA indicator(s) are bullish while REVB’s TA Score has 3 bullish TA indicator(s).

  • CRIS’s TA Score: 4 bullish, 4 bearish.
  • REVB’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CRIS is a better buy in the short-term than REVB.

Price Growth

CRIS (@Biotechnology) experienced а +16.28% price change this week, while REVB (@Biotechnology) price change was -4.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

CRIS is expected to report earnings on Mar 31, 2025.

REVB is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRIS($15M) has a higher market cap than REVB($2.58M). CRIS YTD gains are higher at: -50.980 vs. REVB (-61.293). REVB has higher annual earnings (EBITDA): -7.95M vs. CRIS (-44.56M). CRIS has more cash in the bank: 20.9M vs. REVB (6.5M). REVB has less debt than CRIS: REVB (0) vs CRIS (3.26M). CRIS has higher revenues than REVB: CRIS (10.3M) vs REVB (0).
CRISREVBCRIS / REVB
Capitalization15M2.58M580%
EBITDA-44.56M-7.95M561%
Gain YTD-50.980-61.29383%
P/E RatioN/AN/A-
Revenue10.3M0-
Total Cash20.9M6.5M322%
Total Debt3.26M0-
FUNDAMENTALS RATINGS
CRIS: Fundamental Ratings
CRIS
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRISREVB
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 3 days ago
70%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
41%
View a ticker or compare two or three
Ad is loading...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALKT26.221.12
+4.46%
Alkami Technology
WWD174.236.42
+3.83%
Woodward
SHOT0.40N/A
+0.65%
Safety Shot
SD9.38-0.07
-0.74%
SandRidge Energy
GNLN0.25-0.02
-7.72%
Greenlane Holdings Inc

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-10.92%
GNPX - REVB
48%
Loosely correlated
+3.01%
TCRT - REVB
46%
Loosely correlated
+2.92%
CRIS - REVB
35%
Loosely correlated
+4.90%
TOVX - REVB
31%
Poorly correlated
+2.20%
TSHA - REVB
31%
Poorly correlated
+2.25%
More